Submission Details
| 510(k) Number | K161297 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 09, 2016 |
| Decision Date | June 07, 2016 |
| Days to Decision | 29 days |
| Submission Type | Special |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
K161297 is an FDA 510(k) clearance for the Beta-2-Microglobulin, a System, Test, Beta-2-microglobulin Immunological (Class II — Special Controls, product code JZG), submitted by Beckman Coulter Ireland, Inc. (Co. Clare, IE). The FDA issued a Cleared decision on June 7, 2016, 29 days after receiving the submission on May 9, 2016. This device falls under the Immunology review panel. Regulated under 21 CFR 866.5630.
| 510(k) Number | K161297 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 09, 2016 |
| Decision Date | June 07, 2016 |
| Days to Decision | 29 days |
| Submission Type | Special |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
| Product Code | JZG — System, Test, Beta-2-microglobulin Immunological |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.5630 |